Medbox CEO Featured on Bloomberg

"We have exactly what the states want"

May 17, 2013, 08:59 ET from Medbox, Inc.

HOLLYWOOD, Calif., May 17, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (, a leader in providing consulting services and patented systems to the medical and retail industries, announced today that their CEO, Dr. Bruce Bedrick, was interviewed on Bloomberg Television's Street Smart.

"Marijuana's market potential is massive," Adam Johnson, host of Street Smart stated. "The market for legalized pot could triple by 2018 to $5 billion dollars."

Bedrick was asked about his recent meetings with Wall Street investors. "There's been a tremendous amount of interest," Bedrick stated. "We moved into a new phase in the medical marijuana industry, where you will see an increase of regulation and oversight in states that are developing their legislation for the marijuana industry, and Medbox is perfectly positioned to dominate in that space because of our transparency, our safety, and our security measures," he added. "So Wall Street has gravitated to us because of our technology, because of what we stand for, and because we also have an incredible value proposition in traditional pharmaceutical and healthcare as well."

The Medbox system is a tool for pharmacies and acts as both a pharmacist's assistant and an inventory and compliance tool, the report explained. "The Medbox system is safer, more secure, more cost effective, more convenient and can drive revenue," Bedrick added.

Trish Regan, co-host of Street Smart, asked about the future of the marijuana industry. "The discussion is active," Bedrick stated, "But right now, it's about ancillary services, safety, security, technology and professionalism."

To view the Bloomberg Street Smart story, visit:

For more information on Medbox, visit:

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to

SOURCE Medbox, Inc.